ARTICLE | Company News
Opsona, Wyeth TLR deal
February 15, 2006 3:15 AM UTC
Opsona (Dublin, Ireland) and WYE partnered to discover, develop and commercialize compounds targeting Opsona's toll-like receptor 14 (TLR14) for autoimmune and inflammatory diseases. Opsona will recei...